Partners Austria Gmbh Lansdowne serves as Executive at Alexza Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Partners Austria Gmbh Lansdowne has executed 4 insider transactions totaling $944.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 18, 2013 involved selling 25,000 shares valued at $118.8K.
Partners Austria Gmbh Lansdowne currently holds 1,520,055 shares of Alexza Pharmaceuticals Inc. (ALXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners Austria Gmbh Lansdowne has been a net seller of ALXA stock. They have purchased $350.3K and sold $593.8K worth of shares.
Partners Austria Gmbh Lansdowne's most recent insider trade was on Jan 18, 2013, when they sold 25,000 shares at $4.75 per share.
Get notified when new Form 4 filings are submitted
| $4.75 |
| Discretionary |
| Dec 27, 2012 | ALXA | $138.4K | Purchase | 28,589 | $4.84 | Discretionary |
| Dec 27, 2012 | ALXA | $211.9K | Purchase | 43,600 | $4.86 | Discretionary |